Sugi Predict

Sugi Predict / Compounds / SCHEMBL19620064

SCHEMBL19620064

SCHEMBL19620064

COC(=O)NC(C(=O)N1CCC[C@H]1c1nc(-c2ccc(-c3ccc(-c4c[nH]c([C@@H]5C=CCN5C(=O)[C@H](NC(=O)OC)c5ccccc5)n4)cc3)cc2)c[nH]1)C(C)C

nearest known ligand 0.54

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 7/20 0.54
▸ CYP2C9 P11712 5/20 0.52
▸ KCNH2 Q12809 3/20 0.51
▸ NR1I2 O75469 2/20 0.51
▸ ABCB11 O95342 1/20 0.51
▸ OPRK1 P41145 1/20 0.51
▸ CYP1A2 P05177 3/20 0.47
▸ CYP2D6 P10635 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16282903 1.00 CYP3A4 (0.54) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL17751540 1.00 CYP3A4 (0.54) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL16282930 1.00 CYP3A4 (0.54) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL16282927 1.00 CYP3A4 (0.54) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL16282901 1.00 CYP3A4 (0.54) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL19620065 1.00 CYP3A4 (0.54) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL17751539 1.00 CYP3A4 (0.54) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL16282925 0.95 KCNH2 (0.50) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL17751541 0.95 KCNH2 (0.50) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL16282902 0.95 KCNH2 (0.50) CYP3A4CYP2C9KCNH2NR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9820972-B2 Antiviral compounds highly effective as HCV-NS5A inhibitor AB Pharma Ltd. (CN) 2017-11-21 — — US disclosed